Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Arch Pathol Lab Med ; 145(1): 66-74, 2021 01 01.
Article in English | MEDLINE | ID: mdl-33367662

ABSTRACT

CONTEXT.­: Automated analyzers have advanced the field of clinical hematology, mandating updated complete blood count (CBC) reference intervals (RIs) to be clinically useful. Contemporary newborn CBC RI publications are mostly retrospective, which some authors have cited as one of their cardinal limitations and recommended future prospective studies. OBJECTIVE.­: To prospectively establish accurate hematologic RIs for normal healthy term newborns at 24 hours of life given the limitations of the current medical literature. DESIGN.­: This prospective study was conducted at an academic tertiary care center, and hematology samples were collected from 120 participants deemed to be normal healthy term newborns. Distributions were assessed for normality and tested for outliers. Reference intervals were values between the 2.5th percentile and 97.5th percentile. RESULTS.­: The novel RIs obtained for this study population are as follows: absolute immature granulocyte count, 80/µL to 1700/µL; immature granulocyte percentage, 0.6% to 6.1%; reticulocyte hemoglobin equivalent, 31.7 to 38.4 pg; immature reticulocyte fraction, 35.9% to 52.8%; immature platelet count, 4.73 × 103/µL to 19.72 × 103/µL; and immature platelet fraction, 1.7% to 9.8%. CONCLUSIONS.­: This prospective study has defined hematologic RIs for this newborn population, including new advanced clinical parameters from the Sysmex XN-1000 Automated Hematology Analyzer. These RIs are proposed as the new standard and can serve as a strong foundation for continued research to further explore their value in diagnosing and managing morbidities such as sepsis, anemia, and thrombocytopenia.


Subject(s)
Blood Cell Count/standards , Hematology/standards , Infant, Newborn/blood , Female , Humans , Male , Prospective Studies , Reference Values
2.
J Minim Invasive Gynecol ; 26(6): 1144-1148, 2019.
Article in English | MEDLINE | ID: mdl-30502499

ABSTRACT

STUDY OBJECTIVE: To evaluate if smooth muscle cells can be detected in pelvic washings at the time of intact hysterectomy. DESIGN: A multicentered pilot cohort study (Canadian Task Force classification II-2). SETTING: Two academically affiliated tertiary referral centers. PATIENTS: Patients undergoing total hysterectomy for benign indications without morcellation by minimally invasive gynecologic surgeons were enrolled from January 2018 to July 2018. INTERVENTIONS: Pelvic washings were collected at 2 times during surgery: after abdominal entry and after vaginal cuff closure. Cell blocks were generated, and slides were stained using hematoxylin and eosin, smooth muscle actin, and desmin and interpreted by 1 expert pathologist at each institution. MEASUREMENTS AND MAIN RESULTS: Thirty-eight subjects were recruited; 3 subjects were excluded because of unplanned morcellation. Smooth muscle uterine cells were detected in 1 prewash specimen and 2 postwash specimens. The group with positive washings was noted to have longer procedure times (136 vs 114 minutes), lower blood loss (25 vs 86 mL), and higher uterine weight (242 vs 234 g) compared with negative washings group. CONCLUSION: Tissue dissemination of uterine cells may be possible at the time of hysterectomy. Larger prospective studies are needed to better describe the incidence of and risk factors for tissue dissemination.


Subject(s)
Hysterectomy/methods , Intraoperative Care/methods , Intraoperative Complications/diagnosis , Myocytes, Smooth Muscle/pathology , Pelvis/pathology , Uterine Diseases/surgery , Adult , Body Fluids/cytology , Cohort Studies , Endometriosis/pathology , Endometriosis/surgery , Female , Humans , Hysterectomy/adverse effects , Intraoperative Complications/etiology , Intraoperative Complications/pathology , Intraoperative Period , Laparoscopy/methods , Leiomyoma/pathology , Leiomyoma/surgery , Liquid Biopsy , Middle Aged , Morcellation/adverse effects , Morcellation/methods , Pilot Projects , Prospective Studies , Therapeutic Irrigation , Treatment Outcome , Uterine Diseases/pathology , Uterine Neoplasms/pathology , Uterine Neoplasms/surgery , Uterus/injuries , Uterus/pathology
SELECTION OF CITATIONS
SEARCH DETAIL
...